Hoping to capitalize on consumer outrage, Imprimis Pharmaceuticals (IMMY) plans to sell a cheaper, compounded version of the Restasis dry-eye treatment that is sold by Allergan (AGN) and has been at ...
Back in November, as Allergan was reeling from the news that it could face earlier-than-expected copies of its blockbuster eye drug Restasis, CEO Brent Saunders promised investors that cost cuts were ...
(Reuters) - Shares of Imprimis Pharmaceuticals Inc sky-rocketed as much as 91 percent on Thursday, after the company said it would launch a cheaper alternative to Allergan Plc's controversial dry eye ...
Note: If you use other eye drops in addition to Restasis, you can probably still use those drops while you’re using Restasis. But make sure to check with your doctor about which eye drops are safe to ...
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. An error has occurred. Please try again ...
Yes, people with Medicare Part D who use Restasis may be eligible for a patient assistance program called myAbbVie Assist. This article discusses whether Medicare covers Restasis, Medicare ...
YORKTOWN, Va. (WAVY) – A Vietnam veteran has a costly problem, but the solution is no mystery. Bruce Mears wants the Veterans Administration to resume doing what it was doing for a while: covering his ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Looks like the squeaky (read: annoying!) wheel still ...
Imprimis Pharmaceuticals, Inc. IMMY announced Thursday the release of a 99-cent alternative to Allergan PLC Ordinary Shares AGN's Restasis to address the 30 million Americans suffering from Dry Eye ...
Viatris' generic Restasis will now gain access to a large pool of patients. The FDA approval could lead to a $180 million yearly sales boost for the generic drugmaker. Its stock trades at a P/E ratio ...
The US Food and Drug Administration (FDA) has approved the first generic of cyclosporine ophthalmic emulsion (Restasis) to treat keratoconjunctivitis sicca (dry eye). Restasis has been approved by the ...